Dana Blankenhorn

Rethinking Healthcare

Gene therapy rises again

By Dana Blankenhorn | Nov 6, 2009 |

After several years of frustrating failure, gene therapy is rising again.

In theory gene therapy means finding a way to change a person’s genetic structure so that an inherited condition may be reversed. In practice, it can mean taking a leukemia or HIV virus, altering its genetic structure, and hoping the cure doesn’t turn out to be worse than the disease.

In the latest cases French scientists arrested the progress of ALD, the disease made famous by the movie “Lorenzo’s Oil,” while American scientists showed the potential of gene therapy to reverse a disease causing blindness.

In the French case, detailed at Science, scientists removed blood cells and treated them with a modified HIV virus carrying the gene for the enzyme the patients lacked. Chemotherapy wiped out the patients’ blood marrow, the new cells were infused, and in time these cells began cranking out the needed protein.

It took over a year for evidence to suggest success — one patient lost some vision, the other some points on a non-verbal IQ test — but the general course of the disease had been halted.

The European Leukodystrophies Association (ELA), which has sponsored this research to the tune of 7 million Euros (almost $11 million) was over the moon.

Shown above is one of the two French patients alongside the group’s “ambassador,” former soccer star Zinedine Zidane. (He’s the Frenchman who spat at the Italian rival during the World Cup final. Yeah, that guy. He’s usually very nice.)

The story is heartwarming but the implications are far greater. Many common diseases like cancer are being shown to have a genetic component. As the use of gene therapy increases, and becomes regularized, we could be finding cures that can be used on millions.

That is at least a decade away, but now we know it’s possible. We have a method.

 
Reply to Story

SmartPlanet TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via RSS

  •  
    1

    GarryGR

    11/11/09 | Report as spam

    RE: Gene therapy rises again

    Gene therapy is a step towards the Star Trek Tricoder! happy This is great; this is the kind of advancement that will finally, hopefully, take the far to prevalent hit or miss "art" out of health care / medicine. Unfortunately, it most likely will take decades to get there. But it's the "engineering" solution that's so badly needed.

  •  
    2

    rod.boggess@...

    11/12/09 | Report as spam

    RE: Gene therapy rises again

    "this is the kind of advancement that will finally, hopefully, take the far to prevalent hit or miss 'art' out of health care / medicine."

    Hardly, more like adding a new canvas on which to paint. The Human Genome Project would do more for engineering treatments, but even then, it would take a great deal more understanding to use genetic makeup to simulate a human body and analyze results for possible treatments. I'm afraid that's still hundreds of years in the future.

  •  
    3

    mike@...

    11/18/09 | Report as spam

    RE: Gene therapy rises again

    Gee, I remember visiting Disneyland in the late 1950's and learning that "hundreds of years in the future" men would walk on the moon.

    In 1969, I watched it happen. Imagine.

  •  
    4

    MuratCan

    02/07/10 | Report as spam

    MuratCan

    It is quite common that women usually have the desire to buy new jewelries which are seemed to be better than the old ones.
    sohbet
    sohbet
    kizlarla sohbet
    sohbet
    dini sohbet
    sohbet chat
    mirc indir
    lida
    chat
    sohbet
    lida
    v-pills gold
    muhabbet
    sohbet odalari
    revizyon ile organize matbaacilik brnckvvtmllttrhaberi
    chat
    fx15
    lw6090
    rx1
    biber hapi
    revizyon ile organize matbaacilik brnckvvtmllttrhaberi
    Zaytoz.com - Cakma orumcek Webmaster Forumu 2011 Seo Yarismasi
    rer

The following tags are supported in Smartplanet comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. Name: You are currently: a Guest |
advertisement

Quick Poll

advertisement
Click Here
advertisement
Click Here
advertisement

Dana Blankenhorn

Dana Blankenhorn has been a business journalist for nearly 25 years and has covered the online world professionally since 1985. He founded the Interactive Age Daily for CMP Media, and has written for the Chicago Tribune, Advertising Age's "NetMarketing" supplement, and dozens of other publications over the years.

Dana Blankenhorn

Dana Blankenhorn has been a technology reporter since 1982, a business reporter since 1978, and a writer for as long as he can remember. His Schwab IRA has a few tech stocks in it, most notably some Intel and Applied Materials bought over 10 years ago. But the vast majority of his tiny fortune (emphasis on the word tiny) is invested in mutual funds. He presently writes for no one else but ZDNet, SmartPlanet and himself. But if you've got an opportunity let him know. If he takes the gig he"ll first add it to this disclosure page.
Rethinking Healthcare examines innovation in the health care industry covering topics such as electronic and personal health records, treatment, privacy, regulation and using information technology to manage and monitor chronic conditions.